Inflammation, stress and depression: an exploration of ketamine's therapeutic profile

JN Johnston, MS Greenwald, ID Henter, C Kraus… - Drug discovery today, 2023 - Elsevier
Highlights•Chronic stress, depression and inflammation have been consistently
linked.•Stress-induced inflammatory states can contribute to treatment resistance.•Ketamine …

Illuminating the way: the role of bright light therapy in the treatment of depression

B Kosanovic Rajacic, M Sagud, N Pivac… - Expert Review of …, 2023 - Taylor & Francis
Introduction Despite the growing number of different therapeutic options, treatment of
depression is still a challenge. A broader perspective reveals the benefits of bright light …

The chronic unpredictable mild stress (CUMS) Paradigm: Bridging the gap in depression research from bench to bedside

S Sharma, S Chawla, P Kumar, R Ahmad, PK Verma - Brain Research, 2024 - Elsevier
Depression is a complicated neuropsychiatric condition with an incompletely understood
etiology, making the discovery of effective therapies challenging. Animal models have been …

Lateral hypothalamus orexinergic projection to the medial prefrontal cortex modulates chronic stress-induced anhedonia but not anxiety and despair

D Liu, X Zheng, Y Hui, Y Xu, J Du, Z Du, Y Che… - Translational …, 2024 - nature.com
Chronic stress-induced anxiodepression is a common health problem, however its potential
neurocircuitry mechanism remains unclear. We used behavioral, patch-clamp …

Functional MRI markers for treatment-resistant depression: Insights and challenges

V Kotoula, JW Evans, C Punturieri, SC Johnson… - Progress in brain …, 2023 - Elsevier
Imaging studies of treatment-resistant depression (TRD) have examined brain activity,
structure, and metabolite concentrations to identify critical areas of investigation in TRD as …

SSRIs in the treatment of depression: A pharmacological CUL-DE-SAC?

PJ Cowen - Emerging Neurobiology of Antidepressant Treatments, 2023 - Springer
The widespread adoption of selective serotonin reuptake inhibitors (SSRIs) as first-line
pharmacological treatments in the management of clinical depression transformed the …

Association between overt aggression and anhedonia in patients with major depressive disorder during the acute phase

C Xu, F Wang, Q Huang, D Lyu, C Wu, T Cao… - Journal of psychiatric …, 2023 - Elsevier
Objective To explore the factors influencing anhedonia at baseline and use them as
confounding factors. To further investigate the correlation between overt aggression and …

Effects of anhedonia on health-related quality of life and functional outcomes in major depressive disorder: A systematic review and meta-analysis

S Wong, GH Le, L Phan, TG Rhee, R Ho… - Journal of Affective …, 2024 - Elsevier
Background Major depressive disorder (MDD) is a heterogeneous group of mood disorders.
A prominent symptom domain is anhedonia narrowly defined as a loss of interest and ability …

[HTML][HTML] Meaning in life mediates the effects of sense of self and prosocial behaviours on anhedonia: a path analysis

S Demir-Kassem, AL Frey, C McCabe - Journal of Affective Disorders, 2025 - Elsevier
Background Anhedonia, the loss of interest and pleasure, is a core symptom of depression
that is resistant to treatment. Anhedonic young people describe a weakened sense of self …

Therapeutic Potential of Saffron Extract in Mild Depression: A Study of Its Role on Anhedonia in Rats and Humans

E Corridori, S Salviati, MG Demontis… - Phytotherapy …, 2025 - Wiley Online Library
Drugs generally used in major depressive disorder are considered inappropriate for the
more common milder forms. The efficacy of saffron extracts has been demonstrated in mild …